• Citer

Tacrolimus and cyclosporine have differential effects on the risk of development of bronchiolitis obliterans syndrome: results of a prospective, randomized international trial in lung transplantation.

par Treede, Hendrik;Glanville, Allan R.;Klepetko, Walter;Aboyoun, Christina;Vettorazzi, Eik;Lama, Raffael;Bravo, Carlos;Knoop, Christiane ;Aubert, John-David;Reichenspurner, Hermann;European and Australian Investigators in Lung Transplantation,
Référence The Journal of heart and lung transplantation, 31, 8, page (797-804)
Publication Publié, 2012-08

Article révisé par les pairs

• Accès en ligne
• Détails
• Contenu
• Statistiques

Titre:	Tacrolimus and cyclosporine have differential effects on the risk of development of bronchiolitis obliterans syndrome: results of a prospective, randomized international trial in lung transplantation.
Auteur:	Treede, Hendrik; Glanville, Allan R.; Klepetko, Walter; Aboyoun, Christina; Vettorazzi, Eik; Lama, Raffael; Bravo, Carlos; Knoop, Christiane; Aubert, John-David; Reichenspurner, Hermann; European and Australian Investigators in Lung Transplantation,
Informations sur la publication:	The Journal of heart and lung transplantation, 31, 8, page (797-804)
Statut de publication:	Publié, 2012-08
Sujet CREF:	Sciences bio-médicales et agricoles
Mots-clés:	bronchiolitis obliterans syndrome (BOS)
	calcineurin inhibitors
	chronic rejection
	immunosuppression
	lung transplantation
MeSH keywords:	Adult
	Bronchiolitis Obliterans -- epidemiology -- mortality -- prevention & control
	Cyclosporine -- adverse effects -- therapeutic use
	Female
	Follow-Up Studies
	Graft Rejection -- epidemiology
	Humans
	Immunosuppressive Agents -- adverse effects -- therapeutic use
	Incidence
	International Cooperation
	Lung Transplantation -- mortality
	Male
	Middle Aged
	Outcome Assessment (Health Care)
	Prospective Studies
	Risk Factors
	Survival Rate
	Syndrome
	Tacrolimus -- adverse effects -- therapeutic use
	Treatment Outcome
Note générale:	Journal Article
	Multicenter Study
	Randomized Controlled Trial
	Research Support, Non-U.S. Gov't
	SCOPUS: ar.j
Langue:	Anglais
Identificateurs:	urn:issn:1053-2498
	info:doi/10.1016/j.healun.2012.03.008
	info:pii/S1053-2498(12)01041-8
	info:scp/84863337211
	info:pmid/22554673